GB0139
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GB0139, covering 2024-05-22 to 2024-05-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]